Advocacy Conditions Epilepsy Pharmaceutical 
Cannabis Law Report
DECEMBER 3, 2021
.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Phase 2, Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy (the Violet Study). About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.
Veriheal
FEBRUARY 21, 2023
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
NOVEMBER 17, 2023
By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.
MMJ Recs
FEBRUARY 3, 2024
This guide aims to navigate the intricate web of cannabis legislation in Philadelphia, Pennsylvania, exploring key aspects such as medical marijuana laws, cannabis regulations, qualifying conditions, patient eligibility, and the overall impact on the local cannabis industry.
CannaTech
AUGUST 9, 2018
We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.
NORML
AUGUST 26, 2019
There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.].
Cannabis Law Report
JUNE 26, 2019
I am a medical patient in Florida’s Medical Marijuana Use Registry due my qualifying condition: a 2010 diagnosis of aggressive Multiple Sclerosis. I used to be a pharmaceutical statistic of opiate and controlled substance pain medications, alongside 25 other Multiple Sclerosis symptom-fighting medications for seven long years.
Expert insights. Personalized for you.
52 
Let's personalize your content